Alternative splicing and polyadenylation represent two major steps in premRNA-processing, which ensure proper gene expression and diversificationof human transcriptomes. Deregulation of these processes contributes to oncogenic programmes involved in the onset, progression and evolution ofhuman cancers, which often result in the acquisition of resistance to existingtherapies. On the other hand, cancer cells frequently increase their transcriptionalrate and develop a transcriptional addiction, which imposes ahigh stress on the pre-mRNA-processing machinery and establishes a therapeuticallyexploitable vulnerability. A prominent role in fine-tuning premRNA- processing mechanisms is played by three main families of protein kinases: serine arginine protein kinase (SRPK), CDC-like kinase (CLK) and cyclin-dependent kinase (CDK). These kinases phosphorylate the RNA polymerase, splicing factors and regulatory proteins involved in cleavage and polyadenylation of the nascent transcripts. The activity of SRPKs, CLKs and CDKs can be altered in cancer cells, and their inhibition was shown to exert anticancer effects. In this review, we describe key findings that have been reported on these topics and discuss challenges and opportunities of developing therapeutic approaches targeting splicing factor kinases.

Naro, C., Bielli, P., Sette, C., Oncogenic dysregulation of pre-mRNA processing by protein kinases: challenges and therapeutic opportunities, <<THE FEBS JOURNAL>>, 2021; 2021 (288(21)): 6250-6272. [doi:10.1111/febs.16057] [http://hdl.handle.net/10807/189622]

Oncogenic dysregulation of pre-mRNA processing by protein kinases: challenges and therapeutic opportunities

Naro, Chiara;Sette, Claudio
2021

Abstract

Alternative splicing and polyadenylation represent two major steps in premRNA-processing, which ensure proper gene expression and diversificationof human transcriptomes. Deregulation of these processes contributes to oncogenic programmes involved in the onset, progression and evolution ofhuman cancers, which often result in the acquisition of resistance to existingtherapies. On the other hand, cancer cells frequently increase their transcriptionalrate and develop a transcriptional addiction, which imposes ahigh stress on the pre-mRNA-processing machinery and establishes a therapeuticallyexploitable vulnerability. A prominent role in fine-tuning premRNA- processing mechanisms is played by three main families of protein kinases: serine arginine protein kinase (SRPK), CDC-like kinase (CLK) and cyclin-dependent kinase (CDK). These kinases phosphorylate the RNA polymerase, splicing factors and regulatory proteins involved in cleavage and polyadenylation of the nascent transcripts. The activity of SRPKs, CLKs and CDKs can be altered in cancer cells, and their inhibition was shown to exert anticancer effects. In this review, we describe key findings that have been reported on these topics and discuss challenges and opportunities of developing therapeutic approaches targeting splicing factor kinases.
Inglese
Naro, C., Bielli, P., Sette, C., Oncogenic dysregulation of pre-mRNA processing by protein kinases: challenges and therapeutic opportunities, <<THE FEBS JOURNAL>>, 2021; 2021 (288(21)): 6250-6272. [doi:10.1111/febs.16057] [http://hdl.handle.net/10807/189622]
File in questo prodotto:
File Dimensione Formato  
Oncogenic dysregulation of pre-mRNA.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 562.81 kB
Formato Adobe PDF
562.81 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/189622
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact